Abstract:ABSTRACT Drug addiction can seriously damage human physical and mental health, while detoxification is a long and difficult process. Although studies have reported changes in the oral microbiome of methamphetamine (METH) users, the role that the microbiome plays in the process of drug addiction is still unknown. This study aims to explore the function of the microbiome based on analysis of the variations in the oral microbiome and metabolome of METH users. We performed the 16S rRNA sequencing analysis based on the oral saliva samples collected from 278 METH users and 105 healthy controls (CTL). In addition, the untargeted metabolomic profiling was conducted based on 220 samples. Compared to the CTL group, alpha diversity was reduced in the group of METH users and the relative abundances of Peptostreptococcus and Gemella were significantly increased, while the relative abundances of Campylobacter and Aggregatibacter were significantly decreased. Variations were also detected in oral metabolic pathways, including enhanced tryptophan metabolism, lysine biosynthesis, purine metabolism, and steroid biosynthesis. Conversely, the metabolic pathways of porphyrin metabolism, glutathione metabolism, and pentose phosphate were significantly reduced. It was speculated that four key microbial taxa, i.e., Peptostreptococcus , Gemella , Campylobacter , and Aggregatibacter , could be involved in the toxicity and addiction mechanisms of METH by affecting the above metabolic pathways. It was found that with the increase of drug use years, the content of tryptamine associated with neuropsychiatric disorders was gradually increased. Our study provides novel insights into exploring the toxic damage and addiction mechanisms underlying the METH addiction. IMPORTANCE It was found that with the increase of drug use years, the content of tryptamine associated with neuropsychiatric disorders gradually increased. The prediction models based on oral microbiome and metabolome could effectively predict the methamphetamine (METH) smoking. Our study provides novel insights into the exploration of the molecular mechanisms regulating the toxic damage and addiction of METH as well as new ideas for early prevention and treatment strategies of METH addiction.

Research Progress on the Omics of Methamphetamine Toxic Damage and Addiction

Research progress in drug toxicology based on systems biology

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Current Understanding of Methamphetamine-Associated Metabolic Changes Revealed by the Metabolomics Approach

Variations in the oral microbiome and metabolome of methamphetamine users

Effects and Associated Transcriptomic Landscape Changes of Methamphetamine on Immune Cells.

Advances in the mechanism of methamphetamine addiction

Metabolomics Profiling of Methamphetamine Addicted Human Serum and Three Rat Brain Areas

The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment.

Application of Metabolomics on Toxicology of Drugs Abuse

Alterations in the oral microbiome and metabolome of methamphetamine addicts

Epigenetic mechanisms involved in methamphetamine addiction

The progress in the mechanisms of methamphetamine neurotoxicity

Psychoactive substances and DNA methylation

Function of complement factor H and imaging of small molecules by MALDI-MSI in a methamphetamine behavioral sensitization model.

Epigenome‐wide association study on methamphetamine dependence

The metabolic impact of methamphetamine on the systemic metabolism of rats and potential markers of methamphetamine abuse.

Multidimensional Analysis of the Epigenetic Alterations in Toxicities Induced by Mycotoxins

Peripheral molecular and brain structural profile implicated stress activation and hyperoxidation in methamphetamine use disorder

Neuroproteomics and its applications in research on nicotine and other drugs of abuse.

The role of the microbiota–gut–brain axis in methamphetamine-induced neurotoxicity: Disruption of microbial composition and short-chain fatty acid metabolism